We are live on ! Find out more
Vantage Wealth

Vantage Wealth Portfolio holdings

AUM $463M Turnover 3.33%
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+18.98%
3 Year Est. Return
+56.09%
5 Year Est. Return
+73.82%
10 Year Est. Return
+250.43%
AUM
$171M
AUM Growth
+$14.9M
Cap. Flow
+$8.32M
Cap. Flow %
4.86%
Top 10 Hldgs %
43.33%
Holding
29
New
3
Increased
14
Reduced
9
Closed
2
Avg Time Held
1.3 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$6.21M
2
CVX icon
Chevron
CVX
+$1.18M
3
XOM icon
ExxonMobil
XOM
+$365K
4
QCOM icon
Qualcomm
QCOM
+$342K
5
GE icon
GE Aerospace
GE
+$243K

Sector Composition

Rank Sector Weight
1 Industrials 22.21%
2 Technology 19.96%
3 Financials 16.82%
4 Miscellaneous 14.17%
5 Healthcare 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$4.98T
$9.7M 5.66%
350,996
-11,580
-3% -$315K
2013 Q2
6 quarters
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.21T
$8.72M 5.1%
58,043
-175
-0.3% -$25.3K
2013 Q2
6 quarters
JPM icon
3
JPMorgan Chase
JPM
$825B
$7.32M 4.28%
116,909
+1,860
+2% +$112K
2013 Q2
6 quarters
MMM icon
4
3M
MMM
$91.8B
$7.14M 4.18%
51,984
-2,213
-4% -$284K
2013 Q2
6 quarters
MSFT icon
5
Microsoft
MSFT
$3.6T
$7.08M 4.14%
152,450
+2,450
+2% +$115K
2013 Q2
6 quarters
PEP icon
6
PepsiCo
PEP
$192B
$7.04M 4.12%
74,433
+1,055
+1% +$101K
2013 Q2
6 quarters
NVS icon
7
Novartis
NVS
$284B
$6.93M 4.06%
83,509
+1,367
+2% +$113K
2013 Q2
6 quarters
UPS icon
8
United Parcel Service
UPS
$90.4B
$6.82M 3.99%
61,350
-925
-1% -$97.6K
2013 Q2
6 quarters
JNJ icon
9
Johnson & Johnson
JNJ
$651B
$6.73M 3.94%
64,400
+1,305
+2% +$138K
2013 Q2
6 quarters
BAX icon
10
Baxter International
BAX
$13.1B
$6.55M 3.83%
164,493
+4,050
+3% +$158K
2013 Q4
4 quarters
TROW icon
11
T. Rowe Price
TROW
$21.5B
$6.54M 3.83%
+76,200
New +$6.21M
2014 Q4
0 quarters
GE icon
12
GE Aerospace
GE
$321B
$6.43M 3.76%
53,068
+1,977
+4% +$243K
2013 Q4
4 quarters
ACN icon
13
Accenture
ACN
$131B
$6.39M 3.74%
71,550
-600
-0.8% -$49.8K
2013 Q2
6 quarters
QCOM icon
14
Qualcomm
QCOM
$160B
$6.38M 3.73%
85,842
+4,675
+6% +$342K
2013 Q2
6 quarters
RTX icon
15
RTX
RTX
$257B
$6.32M 3.69%
87,260
+1,835
+2% +$125K
2013 Q2
6 quarters
CVX icon
16
Chevron
CVX
$407B
$6.26M 3.66%
55,800
+10,370
+23% +$1.18M
2013 Q2
6 quarters
V icon
17
Visa
V
$750B
$6.19M 3.62%
94,384
-4,456
-5% -$268K
2013 Q2
6 quarters
XOM icon
18
ExxonMobil
XOM
$653B
$5.95M 3.48%
64,389
+3,915
+6% +$365K
2013 Q2
6 quarters
CL icon
19
Colgate-Palmolive
CL
$78.5B
$5.93M 3.47%
85,649
-2,225
-3% -$150K
2013 Q2
6 quarters
EMR icon
20
Emerson Electric
EMR
$82.8B
$5.67M 3.31%
91,795
+3,520
+4% +$220K
2013 Q2
6 quarters
CNI icon
21
Canadian National Railway
CNI
$73.4B
$5.61M 3.28%
81,425
-2,500
-3% -$171K
2013 Q2
6 quarters
ADP icon
22
Automatic Data Processing
ADP
$119B
$4.59M 2.69%
55,088
-10,957
-17% -$888K
2013 Q2
6 quarters
TPR icon
23
Tapestry
TPR
$23.6B
$486K 0.28%
12,930
– –
2013 Q4
4 quarters
SCHW icon
24
Charles Schwab
SCHW
$156B
– –
-204,175
Closed -$6M –
TEVA icon
25
Teva Pharmaceutical Industries
TEVA
$45.8B
– –
-128,950
Closed -$6.93M –

Similar funds

Vantage Wealth's Q4 2014 Portfolio in Review

As of Q4 2014, Vantage Wealth held 29 positions worth $171M, up 9.6% from $156M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Vantage Wealth deployed $8.32M of net new capital in Q4 2014, opening 3 new positions and adding to 14 existing holdings. Its largest new stake was T. Rowe Price: 76,200 shares worth $6.54M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Automatic Data Processing, an estimated $888K trimmed.

  • Vantage Wealth's largest Q4 2014 buy was T. Rowe Price: 76,200 shares worth $6.54M.
  • Vantage Wealth added most to Chevron in Q4 2014, an estimated $1.18M increase.
  • Vantage Wealth's biggest Q4 2014 reduction was Automatic Data Processing, cutting an estimated $888K.
  • Vantage Wealth fully exited Teva Pharmaceutical Industries in Q4 2014, selling an estimated $6.93M.
  • Vantage Wealth's ten largest holdings make up 43% of its $171M portfolio in Q4 2014.
  • Vantage Wealth opened 3 new positions and closed 2 in Q4 2014.
  • Vantage Wealth's portfolio value rose 9.6% quarter-over-quarter to $171M.

Based on Vantage Wealth's 13F filing for Q4 2014, filed 6 Feb 2015.